Year
Edition number
№8 / 2026
ORIGINAL STUDIES
A.A. Anderzhanova, S.S. Lebedev, D.P. Kotova, M.V. Zhuravleva, S.V. Kotov, Yu.A. Melyoshkina, M.V. Lukina, M.A. Balalaeva
Urinary tract infections in patients of a psychosomatic department: Clinical and demographic features, risk factors, the role of psychopharmacotherapy, and treatment approaches9-19
D.A. Ryshkov, K.V. Rerikh, L.A. Shchepankevich, M.S. Ponomareva, A.V. Zatynko, E.V. Taneeva, I.N. Novikova
Estimation of short-term outcomes of ischemic brain stroke in young adult patients across different age subgroups20-27
A.A. Safiullina, A.A. Petrukhina, R.R. Niyazov, I.V. Zhirov, Yu.F. Osmolovskaya, S.N. Tereshchenko, S.A. Boytsov
Expert Center for idiopathic recurrent pericarditis: First experience in Russia, realities and prospects28-39
N.I. Sobur, E.B. Kleymenova, M.A. Dronov, L.P. Yashina, V.A. Otdelenov
A prospective historically controlled study of the impact of implementing a clinical decision support system on the appropriateness of antimicrobial therapy selection for surgical site infections in traumatology and orthopedics40-49
Yu.Yu. Kupriyanov, I.V. Sychev, V.S. Marmuleva, S.N. Tuchkova, A.V. Lapshtaeva, L.N. Goncharova, K.B. Mirzaev, D.A. Sychev
Prognostic value of ACE, BDKRB2, SLCO1B1, and ABO gene polymorphisms in the treatment of essential hypertension with a combination of enalapril and lercanidipine50-58
E.N. Knyazeva, E.I. Tarlovskaya, N.A. Kamardina
Dynamics of clinical and laboratory parameters in patients with malignant ovarian neoplasms undergoing anticancer therapy59-69
REVIEWS
E.I. Busalaeva, S.M. Zhuchkova, G.A. Gromova
Clinical suspicion, pharmacovigilance, and pharmacogenetics in the prevention of severe outcomes of febrile neutropenia70-78
GUIDELINES FOR PRACTITIONERS
D.A. Mominova, I.B. Belyaeva, V.I. Mazurov, E.A. Trofimov, V.A. Lila, E.S. Zhugrova
Clinical predictors of partial renal response to rituximab therapy in refractory lupus nephritis and associated microvascular retinal disorders (data from real-world clinical practice)80-87
L.V. Selivanova, O.V. Dymova, D.A. Petrenko, I.S. Balkanzhaeva, I.V. Sychev, K.B. Mirzaev, D.A. Sychev
Personalized warfarin therapy adjustment following mechanical heart valve replacement: The role of clinical and pharmacogenetic factors88-97
LECTURE
S.S. Naumov, G.G. Petrosyan, D.A. Sychev
Revision of drug therapy in patients 65 years and older in a medical inpatient unit: Distribution of roles between the general practitioner and clinical pharmacologist98-106
Guideline for practitioners
D.A. Sychev, A.M. Lila, S.A. Bozhkova, L.N. Gavrilenko, S.K. Zyryanov, A.V. Naumov, M.G. Poluektov, I.V. Sorokovikov, E.A. Taskina, R.A. Teryan, N.E. Usacheva
Resolution of the Expert Council: “Evidence base and the role of low-dose multicomponent pharmacotherapy”107-114
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT
A.V. Kryukov
A model for differentiating drug-induced liver injury from COVID-19-associated aminotransferase elevation in hospitalized patients116-126
O.V. Teplyakova
Phenotypes of hip osteoarthritis and the potential for personalized local injection therapy127-138
M.A. Livzan, O.V. Gaus
The role of esophagoprotection in the treatment of gastroesophageal reflux disease with extraesophageal manifestations140-149
L.Z. Bolieva
Azithromycin in asthma: Anti-inflammatory and immunomodulatory mechanisms and therapeutic potential150-157
Activities of RNMOT
Results of the Annual All-Russian Congress with International Participation “Rheumatology Days in Saint Petersburg”
158-160



